Jingfeng Zong

1.8k total citations
67 papers, 1.3k citations indexed

About

Jingfeng Zong is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Jingfeng Zong has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Otorhinolaryngology, 32 papers in Oncology and 28 papers in Surgery. Recurrent topics in Jingfeng Zong's work include Head and Neck Cancer Studies (49 papers), Head and Neck Surgical Oncology (21 papers) and Viral-associated cancers and disorders (12 papers). Jingfeng Zong is often cited by papers focused on Head and Neck Cancer Studies (49 papers), Head and Neck Surgical Oncology (21 papers) and Viral-associated cancers and disorders (12 papers). Jingfeng Zong collaborates with scholars based in China, Hong Kong and United States. Jingfeng Zong's co-authors include Jianji Pan, Qiaojuan Guo, Shaojun Lin, Honglin Chen, Yixin Chen, Tianzhu Lu, Yuanji Xu, Youping Xiao, Shaojun Lin and Jiade J. Lu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Virology.

In The Last Decade

Jingfeng Zong

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingfeng Zong China 19 716 566 476 377 335 67 1.3k
Hao‐Yuan Mo China 16 711 1.0× 598 1.1× 457 1.0× 278 0.7× 294 0.9× 37 1.3k
Shaojun Lin China 17 924 1.3× 530 0.9× 599 1.3× 229 0.6× 200 0.6× 64 1.3k
Dong-Hua Luo China 15 388 0.5× 379 0.7× 258 0.5× 379 1.0× 475 1.4× 24 1.1k
Sing-Fai Leung China 7 409 0.6× 577 1.0× 279 0.6× 359 1.0× 218 0.7× 12 1.1k
Peter M. L. Teo China 14 1.2k 1.7× 788 1.4× 871 1.8× 144 0.4× 181 0.5× 25 1.7k
Hua-Qing Min China 9 436 0.6× 314 0.6× 323 0.7× 126 0.3× 237 0.7× 13 787
G. B. Snow Netherlands 12 302 0.4× 338 0.6× 195 0.4× 129 0.3× 286 0.9× 17 788
M.S. Kies United States 16 296 0.4× 591 1.0× 191 0.4× 81 0.2× 281 0.8× 49 901
Hai‐Qiang Mai China 14 293 0.4× 279 0.5× 162 0.3× 109 0.3× 167 0.5× 36 628
Claudio Dansky Ullmann United States 14 219 0.3× 398 0.7× 139 0.3× 82 0.2× 275 0.8× 26 797

Countries citing papers authored by Jingfeng Zong

Since Specialization
Citations

This map shows the geographic impact of Jingfeng Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingfeng Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingfeng Zong more than expected).

Fields of papers citing papers by Jingfeng Zong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingfeng Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingfeng Zong. The network helps show where Jingfeng Zong may publish in the future.

Co-authorship network of co-authors of Jingfeng Zong

This figure shows the co-authorship network connecting the top 25 collaborators of Jingfeng Zong. A scholar is included among the top collaborators of Jingfeng Zong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingfeng Zong. Jingfeng Zong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Tianzhu, Jingfeng Zong, Yun Xu, et al.. (2023). Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity‐modulated radiotherapy treatment of T4 nasopharyngeal carcinoma. Head & Neck. 45(5). 1130–1140. 4 indexed citations
2.
Lu, Tianzhu, Jingfeng Zong, Chaobin Huang, et al.. (2023). Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach. Radiotherapy and Oncology. 185. 109716–109716. 6 indexed citations
3.
Lin, Cheng, Keyu Lin, Bin Zhang, et al.. (2022). Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma. The Oncologist. 27(4). e340–e349. 13 indexed citations
4.
Xu, Yun, Mengwei Chen, Qiaojuan Guo, et al.. (2021). Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy. Oral Oncology. 121. 105435–105435. 3 indexed citations
5.
Lu, Tianzhu, Yiping Chen, Jieyu Li, et al.. (2020). <p>High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma</p>. OncoTargets and Therapy. Volume 13. 1757–1765. 11 indexed citations
6.
Guo, Qiaojuan, Jingfeng Zong, Tianzhu Lu, et al.. (2019). Systemic immune-inflammation index as a prognostic marker in patients with newly diagnosed metastatic nasopharyngeal carcinoma: a propensity score-matched study. Translational Cancer Research. 8(5). 2089–2098. 1 indexed citations
7.
Guo, Qiaojuan, Tianzhu Lu, Shao Hui Huang, et al.. (2019). Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM. Oral Oncology. 91. 113–120. 8 indexed citations
8.
Zong, Jingfeng, et al.. (2019). The value of plasma EBV DNA in monitoring the therapeutic effect of nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 28(12). 881–884. 2 indexed citations
9.
Tong, Shuang, Bobo Wing-Yee Mok, Jiayan Liu, et al.. (2019). Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma. Frontiers in Oncology. 9. 1120–1120. 45 indexed citations
10.
Lu, Tianzhu, Youping Xiao, Qiaojuan Guo, et al.. (2019). Prognostic value of radiologic extranodal extension and its potential role in future N classification for nasopharyngeal carcinoma. Oral Oncology. 99. 104438–104438. 49 indexed citations
11.
Zong, Jingfeng, Bijuan Chen, Qiaojuan Guo, et al.. (2019). Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma. Radiation Oncology. 14(1). 182–182. 21 indexed citations
12.
Ma, Jennifer, Benjamin H. Lok, Jingfeng Zong, et al.. (2018). Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot. International Journal of Particle Therapy. 4(4). 10–19. 9 indexed citations
13.
Zong, Jingfeng, Qingting Huang, Qiaojuan Guo, & Jianji Pan. (2016). Evolution of the Chinese staging system for nasopharyngeal carcinoma. Chinese Clinical Oncology. 5(2). 19–19. 13 indexed citations
14.
Lin, Shaojun, Xiaozhong Chen, Xiayun He, et al.. (2015). Preliminary results of a prospective multicenter study on clinical staging system for nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 24(3). 275–280. 3 indexed citations
15.
Zheng, Wei, Yuanji Xu, Sufang Qiu, et al.. (2015). Analysis on Clinical Characteristics and Influencing Factors of Patients with Locoregionally Advanced Nasopharyngeal Carcinoma. Asian Pacific Journal of Cancer Prevention. 16(10). 4393–4399. 5 indexed citations
16.
Chen, Juhui, Jingfeng Zong, Junxin Wu, & Jianji Pan. (2015). [Prognostic analysis of nasopharyngeal carcinoma patients with distant metastasis after curative radiotherapy].. PubMed. 37(3). 216–21. 5 indexed citations
17.
Lin, Shaojun, Jianji Pan, Lu Han, et al.. (2013). Long-term outcome of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiotherapy and chemotherapy. Zhonghua fangshe zhongliuxue zazhi. 22(5). 378–382. 1 indexed citations
18.
Zong, Jingfeng, et al.. (2013). Value of cranial nerve involvement found on MRI in staging of nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 22(3). 220–224. 1 indexed citations
19.
Lin, Shaojun, et al.. (2012). A Retrospective Concurrent Control Study of Induction Chemotherapy in 104 Patients with Stage II Nasopharyngeal Carcinoma. 39(24). 2018–2021. 1 indexed citations
20.
Chen, Yong, Shaobo Liang, Yan‐Ping Mao, et al.. (2008). A prospective randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Clinical Oncology and Cancer Research. 35(14). 785–789. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao‐Yuan Mo Breakdown of academic impact, for papers by Shaojun Lin Breakdown of academic impact, for papers by Dong-Hua Luo Breakdown of academic impact, for papers by Sing-Fai Leung Breakdown of academic impact, for papers by Peter M. L. Teo Breakdown of academic impact, for papers by Hua-Qing Min Breakdown of academic impact, for papers by G. B. Snow Breakdown of academic impact, for papers by M.S. Kies Breakdown of academic impact, for papers by Hai‐Qiang Mai Breakdown of academic impact, for papers by Claudio Dansky Ullmann
Rankless by CCL
2026